Cargando…
m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
BACKGROUND: METTL3 is an RNA methyltransferase that mediates m(6)A modification and is implicated in mRNA biogenesis, decay, and translation. However, the biomechanism through which METTL3 regulates MALAT1-miR-1914-3p-YAP axis activity to induce NSCLC drug resistance and metastasis is not very clear...
Autores principales: | Jin, Dan, Guo, Jiwei, Wu, Yan, Du, Jing, Yang, Lijuan, Wang, Xiaohong, Di, Weihua, Hu, Baoguang, An, Jiajia, Kong, Lingqun, Pan, Lei, Su, Guoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902496/ https://www.ncbi.nlm.nih.gov/pubmed/31818312 http://dx.doi.org/10.1186/s13045-019-0830-6 |
Ejemplares similares
-
m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
por: Jin, Dan, et al.
Publicado: (2021) -
Correction to: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
por: Jin, Dan, et al.
Publicado: (2020) -
Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
por: Jin, Dan, et al.
Publicado: (2023) -
The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC
por: Jin, Dan, et al.
Publicado: (2018) -
Repression of YAP by NCTD disrupts NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2016)